8-K (수시 보고서)
인슐릿 (PODD)
🇺🇸 SEC 공시 8-K 수시공시 중요 원문보기
제출일: 2026-09-21
중요 계약 체결
Item 1.01
공시 항목
Item 1.01 중요
중요 계약 체결
Item 1.01 Entry into a Material Definitive Agreement. On September 21, 2026, Insulet Corporation (the “ Company ”) entered into the Ninth Amendment to Credit Agreement (the “ Amendment ”) with the lenders and other parties thereto and Morgan Stanley Senior Funding, Inc., as administrative agent (the “ Agent ”), amending that certain Credit Agreement, dated as of May 4, 2021 (as previously amended, supplemented or modified, the “ Credit Agreement ”, and as amended by the Amendment, the “ Am...
Item 2.03
직접적 재무 의무 발생
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under Item 1.01 above is incorporated by reference into this Item 2.03.
공시 기본 정보
폼 유형 8-K
종목 PODD (인슐릿)
제출일 2026-09-21
Accession No. 0001193125-26-396779

SEC 공시 자료는 미국 증권거래위원회(SEC)에 제출된 공식 서류입니다. AI 분석 결과는 참고용일 뿐입니다.
Source: SEC EDGAR